Literature DB >> 23726365

Comparison of real time diagnostic chemistries to detect Pseudomonas aeruginosa in respiratory samples from cystic fibrosis patients.

J L Fothergill1, M J Ledson, M J Walshaw, P S McNamara, K W Southern, C Winstanley.   

Abstract

BACKGROUND: Early eradication therapy is key to keeping the airways Pseudomonas aeruginosa infection-free and rapid identification is essential.
METHODS: We used rapid DNA extraction and qPCR assays to detect bacterial, P. aeruginosa and strain-specific targets in samples using two qPCR chemistries. Using 459 respiratory samples from adult and children CF patients, we compared two qPCR methods to culture-based methods in terms of sensitivity and time to result.
RESULTS: For adult samples, there was 100% concordance between methods. There was no clear pattern in fluctuations in P. aeruginosa number during exacerbation. In child samples, qPCR methods identified additional P. aeruginosa positive samples. The time-to-result was reduced by over 24h and copy number and colony forming unit could differ dramatically in some samples.
CONCLUSION: If adopted, these methods could significantly improve early P. aeruginosa detection in diagnostic laboratories and therefore play a pivotal role in prolonging infection-free airways in CF patients.
Copyright © 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic infection; Cystic fibrosis; Diagnostic testing; Early colonisation; Pseudomonas aeruginosa; qPCR

Mesh:

Substances:

Year:  2013        PMID: 23726365     DOI: 10.1016/j.jcf.2013.04.007

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  7 in total

1.  Rapid detection of four non-fermenting Gram-negative bacteria directly from cystic fibrosis patient's respiratory samples on the BD MAX™ system.

Authors:  Talita T Rocchetti; Suzane Silbert; Alicia Gostnell; Carly Kubasek; Robert Jerris; Jennifer Vong; Raymond Widen
Journal:  Pract Lab Med       Date:  2018-05-24

2.  Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response.

Authors:  John C Lam; Ranjani Somayaji; Michael G Surette; Harvey R Rabin; Michael D Parkins
Journal:  BMC Infect Dis       Date:  2015-03-22       Impact factor: 3.090

3.  Lytic activity by temperate phages of Pseudomonas aeruginosa in long-term cystic fibrosis chronic lung infections.

Authors:  Chloe E James; Emily V Davies; Joanne L Fothergill; Martin J Walshaw; Colin M Beale; Michael A Brockhurst; Craig Winstanley
Journal:  ISME J       Date:  2014-12-02       Impact factor: 10.302

4.  Acute effects of viral respiratory tract infections on sputum bacterial density during CF pulmonary exacerbations.

Authors:  Melanie Chin; Maya De Zoysa; Robert Slinger; Ena Gaudet; Katherine L Vandemheen; Francis Chan; Lucie Hyde; Thien-Fah Mah; Wendy Ferris; Ranjeeta Mallick; Shawn D Aaron
Journal:  J Cyst Fibros       Date:  2014-12-18       Impact factor: 5.482

Review 5.  Exploring the Cystic Fibrosis Lung Microbiome: Making the Most of a Sticky Situation.

Authors:  Christina S Thornton; Nicole Acosta; Michael G Surette; Michael D Parkins
Journal:  J Pediatric Infect Dis Soc       Date:  2022-09-07       Impact factor: 5.235

6.  Transmission and lineage displacement drive rapid population genomic flux in cystic fibrosis airway infections of a Pseudomonas aeruginosa epidemic strain.

Authors:  David Williams; Joanne L Fothergill; Benjamin Evans; Jessica Caples; Sam Haldenby; Martin J Walshaw; Michael A Brockhurst; Craig Winstanley; Steve Paterson
Journal:  Microb Genom       Date:  2018-03-16

Review 7.  Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations.

Authors:  Kate Skolnik; Bradley S Quon
Journal:  F1000Res       Date:  2018-05-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.